Focus on multiple myeloma at ASH 2015Zojer, Niklas · memo - Magazine of European Medical Oncology · 2016

Therapeutic Options in Multiple Myeloma: Focus on BortezomibRoodman, G. David · Clinical Medicine. Therapeutics · 2009

<p>Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma</p>Parrondo, Ricardo D; Sher, Taimur · OncoTargets and Therapy · 2019

Management of Multiple Myeloma and Myelodysplastic Syndrome: Focus on LenalidomideVolk, Christine; Klein, Ulrike · Clinical Medicine. Therapeutics · 2009

The Multiple Myeloma Research Foundation's evolving focus on drug R&DGiusti, Kathy · Nature Biotechnology · 2012

Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibLonial, Sagar · Biologics: Targets and Therapy · 2013

Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myelomaFriend, Reed; Bhutani, Manisha; Voorhees, Peter; Usmani, Saad · Drug Design, Development and Therapy · 2017

In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M. Negri; Douglas W. McMillin; Jake Delmore; Nicholas Mitsiades; Patrick Hayden; Steffen Klippel; Teru Hideshima; Dharminder Chauhan; Nikhil C. Munshi; Carolyn A. Buser; John Pollard; Paul G. Richardson; Kenneth C. Anderson; Constantine S. Mitsiades · 2009

Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironmentConstantine S. Mitsiades; Nicholas S. Mitsiades; Paul G. Richardson; Nikhil C. Munshi; Kenneth C. Anderson · 2007

The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactionsConstantine S. Mitsiades; Nicholas S. Mitsiades; Nikhil C. Munshi; Paul G. Richardson; Kenneth C. Anderson · 2006